Comments
Loading...
GRAIL (NASDAQ:GRAL) Stock Quotes, Forecast and News Summary
GRAIL Stock (NASDAQ: GRAL) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy GRAIL (GRAL) stock?
You can purchase shares of GRAIL (NASDAQ:GRAL) through any online brokerage.
Who are GRAIL (GRAL) competitors?
Other companies in GRAIL’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), 89bio (NASDAQ:ETNB), Arcutis Biotherapeutics (NASDAQ:ARQT), Agios Pharmaceuticals (NASDAQ:AGIO) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).
What is the forecast, or price target, for GRAIL (GRAL) stock?
GRAIL has a consensus price target of $16.00.
What is the current price for GRAIL (GRAL)?
The stock price for GRAIL (NASDAQ: GRAL) is $53.0557 last updated February 19, 2025 at 2:34 PM EST.
Does GRAIL (GRAL) pay a dividend?
There are no upcoming dividends for GRAIL.
When is GRAIL (NASDAQ:GRAL) reporting earnings?
GRAIL’s Q1 earnings are confirmed for Thursday, May 15, 2025.
Is GRAIL (GRAL) going to split?
There is no upcoming split for GRAIL.
What sector and industry does GRAIL (GRAL) operate in?
GRAIL is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.